FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 5.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,901,000 | -46.7% | 77,021 | -75.9% | 0.00% | -33.3% |
| Q4 2020 | $5,438,000 | +329.9% | 319,699 | +18.7% | 0.00% | +200.0% |
| Q3 2020 | $1,265,000 | -28.2% | 269,237 | -6.8% | 0.00% | 0.0% |
| Q2 2020 | $1,763,000 | +1186.9% | 289,029 | +379.2% | 0.00% | – |
| Q1 2020 | $137,000 | +33.0% | 60,311 | +167.5% | 0.00% | – |
| Q4 2019 | $103,000 | -52.8% | 22,543 | -60.0% | 0.00% | – |
| Q3 2019 | $218,000 | -19.3% | 56,314 | +25.5% | 0.00% | – |
| Q2 2019 | $270,000 | +47.5% | 44,855 | +227.8% | 0.00% | – |
| Q1 2019 | $183,000 | +28.9% | 13,682 | -10.2% | 0.00% | – |
| Q4 2018 | $142,000 | -63.7% | 15,241 | -45.8% | 0.00% | – |
| Q3 2018 | $391,000 | -41.2% | 28,105 | -33.2% | 0.00% | -100.0% |
| Q2 2018 | $665,000 | +8.8% | 42,067 | +18.3% | 0.00% | 0.0% |
| Q1 2018 | $611,000 | +27.6% | 35,550 | +62.8% | 0.00% | – |
| Q4 2017 | $479,000 | -56.5% | 21,834 | -18.8% | 0.00% | -100.0% |
| Q3 2017 | $1,100,000 | +55.1% | 26,889 | +14.1% | 0.00% | 0.0% |
| Q2 2017 | $709,000 | +98.0% | 23,559 | +137.6% | 0.00% | 0.0% |
| Q1 2017 | $358,000 | -85.0% | 9,917 | -79.2% | 0.00% | -66.7% |
| Q4 2016 | $2,388,000 | -8.8% | 47,656 | -4.4% | 0.00% | -25.0% |
| Q3 2016 | $2,618,000 | +44.6% | 49,867 | +13.9% | 0.00% | +33.3% |
| Q2 2016 | $1,810,000 | +4.4% | 43,765 | +2.6% | 0.00% | 0.0% |
| Q1 2016 | $1,733,000 | +640.6% | 42,664 | +656.1% | 0.00% | – |
| Q4 2015 | $234,000 | – | 5,643 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|